Iradimed Corporation Announced the Pricing of An Underwritten Secondary Offering of Common Stock

Iradimed Corporation (NASDAQ:IRMD) has revealed the pricing of an underwritten secondary offering of 1,043,479 shares of common stock by Roger Susi, the President and Chief Executive of the Company (the “Selling Shareholder”).
According to the press release:

The Selling Shareholder has also granted the underwriters a 30-day option to acquire an additional 156,521 shares to cover overallotments in connection with the offering.  The shares will be offered at a price of $24.25 per share.  The offering is expected to close on December 23, 2015, subject to customary closing conditions.
Roth Capital Partners is acting as the sole manager for the offering.
The Company will not receive any proceeds from the offering.
The shares described above are being offered by the Selling Stockholder pursuant to the Company’s shelf registration statement filed with the Securities and Exchange Commission (“SEC”).  An electronic preliminary prospectus relating to the offering has been filed with the SEC and is available on the SEC’s website at https://www.sec.gov.  Also, a prospectus supplement relating to the offering will be filed with the SEC and will be available on the SEC’s website at https://www.sec.gov.

Click here to read the full press release.